-
1 Comment
Harbin Medisan Pharmaceutical Co., Ltd is currently in a long term uptrend where the price is trading 94.5% above its 200 day moving average.
From a valuation standpoint, the stock is 61.6% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.7.
Harbin Medisan Pharmaceutical Co., Ltd's total revenue sank by 28.0% to $339M since the same quarter in the previous year.
Its net income has dropped by 122.5% to $-6M since the same quarter in the previous year.
Finally, its free cash flow grew by 380.3% to $25M since the same quarter in the previous year.
Based on the above factors, Harbin Medisan Pharmaceutical Co., Ltd gets an overall score of 3/5.
| Exchange | SHE |
|---|---|
| CurrencyCode | CNY |
| ISIN | CNE1000032V9 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | 4B |
|---|---|
| PE Ratio | 65.39 |
| Target Price | 16.13 |
| Dividend Yield | 1.7% |
| Beta | 0.43 |
Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical product and medical devices in China. The company offers various drugs for nervous system, cardiovascular system, musculoskeletal system, systemic anti-infective, basic infusions, nutritional infusion, anti-tumor and immunomodulators, digestive tract, metabolism, etc. It also produces and sells cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 002900.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
